PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

AML score that combines genetic and epigenetic changes might help guide therapy

2014-01-08
(Press-News.org) Contact information: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University Wexner Medical Center
AML score that combines genetic and epigenetic changes might help guide therapy COLUMBUS, Ohio – Currently, doctors use chromosome markers and gene mutations to determine the best treatment for patients with acute myeloid leukemia (AML). But a new study suggests that a score based on seven mutated genes and the epigenetic changes that the researchers discovered were also present might help guide treatment by identifying novel subsets of patients. The findings, published in the Journal of Clinical Oncology, come from a study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). The epigenetic change used in the study is DNA methylation. It involves the addition of methyl groups to DNA, which can reduce or silence a gene's activity, or expression. Abnormal DNA methylation alters normal gene expression and often plays an important role in cancer development. Overall, the findings suggest that patients with a low score – indicating that one or none of the seven genes is overexpressed in AML cells – had the best outcomes, and that patients with high scores – that is, with six or seven genes highly expressed – had the poorest outcomes. "To date, disease classification and prognostication for AML patients have been based largely on chromosomal and genetic markers," says principal investigator Clara D. Bloomfield, MD, Distinguished University Professor, Ohio State University Cancer Scholar and Senior Adviser. "Epigenetic changes that affect gene expression have not been considered. Here we show that epigenetic changes in previously recognized and prognostically important mutated genes can identify novel patient subgroups, which might better help guide therapy," says Bloomfield, who is also the William Greenville Pace III Endowed Chair in Cancer Research at Ohio State. The seven-gene panel was identified in 134 patients aged 60 and older with cytogenetically normal acute myeloid leukemia (CN-AML) who had been treated on Cancer and Leukemia Group B (CALGB)/Alliance clinical trials. The researchers computed a score based on the number of genes in the panel that were highly expressed in patients' AML cells, and retrospectively tested the score in two groups of older patients (age 60 and up) and two groups of younger patients (age 59 and under). Patients with a low score – indicating that one or none of the seven genes is overexpressed – had the best outcomes. Patients with high scores – that is, with six or seven genes highly expressed – had the poorest outcomes. "For this seven-gene panel, the fewer highly expressed genes, the better the outcome," says first author Guido Marcucci, MD, professor of medicine and the associate director for translational research at the OSUCCC – James. "In both younger and older patients, those who had no highly expressed genes, or had one highly expressed gene had the best outcomes." Most adults with AML are not cured by current therapies. Only about 40 percent of patients younger than age 60 and about 10 percent of patients 60 and older are alive after three years, so new strategies for treating the disease and for matching the right patient with the right treatment are needed, Bloomfield says. For this study, Bloomfield, Marcucci and their colleagues used next-generation sequencing to analyze regions of methylated DNA associated with prognostically important gene mutations in CN-AML cells from 134 patients aged 60 and older. The seven genes identified by the researchers were CD34, RHOC, SCRN1, F2RL1, FAM92A1, MIR155HG and VWA8. For each of these genes, lower expression and higher DNA methylation were associated with better outcome. A summary score was developed based on the number of genes in the panel showing high expression. The researchers validated the score in four sets of patients: older and younger patients with primary AML, and older and younger patients with CN-AML (355 patients total). When Bloomfield, Marcucci and their collaborators applied the unweighted score to the initial training set of 134 older patients, those with one or no highly expressed genes had a 96 percent complete-remission rate, 32 percent three-year disease-free survival rate and 39 percent three-year overall survival. Patients with six-to-seven highly expressed genes, on the other hand, had a 25 percent complete-remission rate, a 0 percent three-year disease-free survival rate and 4 percent three-year overall survival. For younger adult patients, those under age 60, those with one or no highly expressed genes had a 91-100 percent complete-remission rate, a 60-65 percent three-year disease-free survival rate, and a 76-82 percent three-year overall survival. Patients with six-to-seven highly expressed genes, on the other hand, had a 53-71 percent complete-remission rate, a 13-17 percent three-year disease-free survival rate and a 7-24 percent three-year overall survival. "Overall, our findings suggest that the unweighted-summary score is a better model compared with all other prognostic markers and previously reported gene-expression profiles," Bloomfield says. ### Funding from the National Institutes of Health/National Cancer Institute (grants CA101140, CA114725, CA31946, CA33601, CA16058, CA77658, CA129657, CA140158); The Coleman Leukemia Research Foundation; the Deutsche Krebshilfe-Dr. Mildred Scheel Cancer Foundation; the Pelotonia Fellowship Program; and the Conquer Cancer Foundation supported this research. Other researchers involved in this study were Pearlly Yan, David Frankhouser, Klaus H. Metzeler, Krzysztof Mrózek, Yue-Zhong Wu, Donna Bucci, John P. Curfman, Susan P. Whitman, Ann-Kathrin Eisfeld, Jason H. Mendler, Sebastian Schwind, Heiko Becker, John C. Byrd, Ramiro Garzon, Michael A. Caligiuri, Stefano Volinia and Ralf Bundschuh, The Ohio State University; Kati Maharry, Deedra Nicolet and Jessica Kohlschmidt, Ohio State University and the Alliance for Clinical Trials in Oncology Statistics and Data Center; Constance Bär and Christoph Plass, German Cancer Research Center, Heidelberg, Germany; Andrew J. Carroll, University of Alabama; Maria R. Baer, University of Maryland; Meir Wetzler, Roswell Park Cancer Institute; Thomas H. Carter, University of Iowa; Bayard L. Powell, Wake Forest University; Jonathan E. Kolitz, Monter Cancer Center; and Richard M. Stone, Dana Farber Cancer Institute. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only four centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 228-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S.News & World Report.


ELSE PRESS RELEASES FROM THIS DATE:

Cosmetic outcomes after breast-conserving therapy may vary by race

2014-01-08
Cosmetic outcomes after breast-conserving therapy may vary by race Subjective ratings appear lower in African-American patients, reports PRS Global Open Philadelphia, Pa. (January 7, 2013) – As perceived by both patients and doctors, the cosmetic results ...

Stopping tumors in their path

2014-01-08
Stopping tumors in their path New study sheds light on most common and deadly form of brain cancer Glioblastoma (GBM) is the most common and deadly form of primary malignant brain cancer accounting for approximately 15% of all brain tumours and occurring mostly in adults between ...

Study shows women continue to outlive men as numbers of centenarians on the rise

2014-01-08
Study shows women continue to outlive men as numbers of centenarians on the rise TORONTO, January 8, 2014 – The number of centenarians in Ontario increased by more than 70 per cent over the last 15 years with women making up more than 85 per cent ...

Researchers at Case Comprehensive Cancer Center discover ovarian cancer biomarker

2014-01-08
Researchers at Case Comprehensive Cancer Center discover ovarian cancer biomarker MicroRNA predicts treatment response Researchers at Case Western Reserve University have identified a microRNA biomarker that shows promise in predicting treatment ...

Negative feedback makes cells 'sensitive'

2014-01-08
Negative feedback makes cells 'sensitive' New research has shown that negative feedback loops in cell signalling systems can be essential for a cell's ability to perceive the strength of a growth stimulus. Cells lacking the feedback loop became insensitive ...

Heart attacks hit poor the hardest

2014-01-08
Heart attacks hit poor the hardest Tel Aviv University researchers show that socioeconomic status is predictor of higher risk of disease and death after an attack As people get older, their bodies wear down and become less resilient. In old age, it's ...

The ironic (and surprising) effects of weight stigma

2014-01-08
The ironic (and surprising) effects of weight stigma UCSB psychology professor finds that messages designed to encourage weight loss may actually have the opposite effect (Santa Barbara, Calif.) — If you're one of the millions of people who ...

Penn biologists establish new method for studying RNA's regulatory 'footprint'

2014-01-08
Penn biologists establish new method for studying RNA's regulatory 'footprint' Increasingly, biologists have come to realize that RNA is not merely a transitional state between DNA and proteins but plays a major role in determining whether and how genes ...

Scripps Florida scientists identify possible key to drug resistance in Crohn's disease

2014-01-08
Scripps Florida scientists identify possible key to drug resistance in Crohn's disease JUPITER, FL, January 7, 2014 – Two-thirds to three-quarters of the estimated 700,000 Americans living with Crohn's disease, an autoimmune condition that can disrupt the entire ...

Massive exoplanets may be more Earth-like than thought

2014-01-08
Massive exoplanets may be more Earth-like than thought 'Super-Earths' likely to have both oceans and continents Massive terrestrial planets, called "super-Earths," are known to be common in our galaxy, the Milky Way. Now a Northwestern University astrophysicist ...

LAST 30 PRESS RELEASES:

Printed skin to replace animal testing

Precision medicine could be possible in the fight against antibiotic resistance

Researchers at the Lewis Katz School of Medicine at Temple University identify new targeted approach to protect neurons against degeneration

Western diet causes inflammation, traditional African food protects

Electrochemical method supports nitrogen circular economy

How researchers are shining a light on kidney disease

Some gut bacteria could make certain drugs less effective

PEPITEM sequence shows effects in psoriasis, comparable to steroid cream

Older teens who start vaping post-high school risk rapid progress to frequent use

Corpse flowers are threatened by spotty recordkeeping

Riding the AI wave toward rapid, precise ocean simulations

Are lifetimes of big appliances really shrinking?

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

[Press-News.org] AML score that combines genetic and epigenetic changes might help guide therapy